OneAscent Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

OneAscent Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$358K	Sell	5,910 -181	-3%	-$10.6K	0.12%	97
2025 Q4	$329K	Sell	6,091 -218	-3%	-$10.5K	0.11%	103
2025 Q3	$285K	Sell	6,309 -45	-0.7%	-$2.1K	0.1%	127
2025 Q2	$294K	Buy	6,354 +414	+7%	+$20.3K	0.11%	117
2025 Q1	$362K	Buy	5,940 +467	+9%	+$27.2K	0.16%	75
2024 Q4	$310K	Sell	5,473 -406	-7%	-$22.7K	0.13%	106
2024 Q3	$304K	Buy	+5,879	New	+$276K	0.12%	126
2024 Q2	–	Sell	-5,992	Closed	-$325K	–	105
2024 Q1	$325K	Buy	5,992 +288	+5%	+$14.7K	0.12%	117
2023 Q4	$293K	Buy	+5,704	New	+$299K	0.12%	120
2023 Q2	–	Sell	-4,959	Closed	-$344K	–	114
2023 Q1	$344K	Sell	4,959 -731	-13%	-$51.6K	0.13%	102
2022 Q4	$409K	Buy	5,690 +8	+0.1%	+$603	0.19%	66
2022 Q3	$404K	Buy	5,682 +1,569	+38%	+$114K	0.21%	56
2022 Q2	$317K	Sell	4,113 -187	-4%	-$14.2K	0.16%	103
2022 Q1	$314K	Sell	4,300 -256	-6%	-$17.2K	0.16%	135
2021 Q4	$284K	Buy	+4,556	New	+$267K	0.71%	61

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OneAscent Wealth Management's BMY Position: Q1 2026 in Review

OneAscent Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 3% in Q1 2026, selling an estimated $10.6K and leaving 5,910 shares worth $358K. The position accounts for 0.12% of the portfolio, ranked #97.

OneAscent Wealth Management first reported a position in BMY in Q4 2021 and has held it in 15 quarters since. The position peaked at $409K in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

OneAscent Wealth Management held 5,910 shares of Bristol-Myers Squibb worth $358K as of Q1 2026.
OneAscent Wealth Management sold 181 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.6K.
Bristol-Myers Squibb made up 0.12% of OneAscent Wealth Management's portfolio in Q1 2026, its #97 holding.
OneAscent Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 15 quarters since.
OneAscent Wealth Management's Bristol-Myers Squibb position peaked at $409K in Q4 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on OneAscent Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.